SAN CARLOS, Calif.--(BUSINESS WIRE)--The Lipoprotein(a) Foundation announced the Centers for Disease Control and Prevention (CDC) has approved two ICD-10 codes for the diagnosis of elevated ...

Roche has received the US Food and Drug Administration’s (FDA) breakthrough device designation for its Tina-quant lipoprotein Lp(a) RxDx assay, a diagnostic tool for cardiovascular disease risk. This ...

Dennis R. Leahy, MD, shares his POV on the value of making Lp(a) testing universal, not only to inform patients and their clinicians of the high CV risks, but to make way for potential treatments.

A blood test that measures lipoprotein(a) [Lp(a)] has received breakthrough device designation from the US Food and Drug Administration. The Tina-quant Lp(a) RxDx assay, developed by Roche in ...

Anjali advises that specific nutrients could aid in the progressive reduction of Lp(a) levels When people think about cholesterol and heart health, they usually focus on total cholesterol and LDL ...

Researchers from University of California San Diego School of Medicine have found that testing for lipoprotein(a) — a genetic risk factor for heart disease — remains uncommon in the United States, ...

The results of a recent retrospective analysis of electronic health record (EHR) data found that only 0.4% of patients with atherosclerotic cardiovascular disease (ASCVD) were tested for lipoprotein(a ...

A new study has drawn attention to inaccurate measurement of LDL-cholesterol levels in some patients with current assays, which could lead to incorrect therapeutic approaches. The patient groups most ...

When considering risk factors for heart attacks and strokes, most people think of the usual players: LDL cholesterol (think L for lousy, or “bad”), HDL cholesterol (think H for healthy, or “good”), ...